FDA Adverse Event Other Summary report: N

OLYMPUS VISERA CYSTO-NEPHRO VIDEOSCOPE

MDR report key: 1553727 · Received November 25, 2009

Report

Report Number
9610773-2009-00019
Event Type
Other
Date Received
November 25, 2009
Date of Event
August 19, 2009
Report Date
August 19, 2009
Manufacturer
OLYMPUS WINTER & IBE GMBH
Product Code
FAJ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE REFERENCED IN THIS REPORT WAS NOT RETURNED TO OLYMPUS FOR EVAL. THE DEVICE WAS REPORTEDLY SENT TO A THIRD-PARTY SERVICE PROVIDER FOLLOWING THE EVENT. OLYMPUS FOLLOWED UP WITH THE USER FACILITY TO OBTAIN ADD'L INFO REGARDING THE REPORTED EVENTS AND WAS INFORMED THAT THE PHYSICIAN BELIEVED THAT THE PT WAS HYPERSENSITIVE TO THE CIDEX OPA REPROCESSING AGENT USED TO DISINFECT THE SCOPE. THE PHYSICIAN STATED THAT HE DID NOT SUSPECT THE SCOPE TO BE THE CAUSE OF THE PT'S EXPERIENCE. THE PHYSICIAN REPORTED USING THE SAME MODEL OF DEVICE ON THIS PT AT A DIFFERENT FACILITY WITH NO COMPLICATIONS. THE CAUSE OF THE PT'S OUTCOME COULD NOT BE CONCLUSIVELY DETERMINED. HOWEVER, IMPROPER REPROCESSING OF THE CYSTOSCOPE AND/OR THIRD PARTY REPAIRS CANNOT BE RULED OUT AS CONTRIBUTORY FACTORS. IF SIGNIFICANT INFO BECOMES AVAILABLE LATER, THIS REPORT WILL BE UPDATED. THIS REPORT IS BEING SUBMITTED AS AN MDR IN AN ABUNDANCE OF CAUTION. SEE ALSO MFR# 9610773-2009-00018 FOR A RELATED REPORT.

Description of Event or Problem · 1

THE USER FACILITY REPORTED THAT A PT DEVELOPED ALLERGIC REACTIONS WITH LOCALIZED INFLAMMATION DURING CYSTOSCOPY PROCEDURES ON TWO SEPARATE OCCASIONS. THE PHYSICIAN REPORTED THAT THE PT'S GLANS PENIS BECAME INFLAMED DURING THE PROCEDURES. THE PROCEDURES WERE COMPLETED USING THE SAME DEVICE. THE PT WAS PROVIDED BENADRYL AND WAS RELEASED FROM THE PHYSICIAN'S CLINIC THE SAME DAY OF THE PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 OLYMPUS VISERA CYSTO-NEPHRO VIDEOSCOPE CYSTOSCOPE FAJ OLYMPUS WINTER & IBE GMBH CYF-V2 NA

Patients

Seq Age Sex Outcome Treatment
1